Albert Torri

Albert Torri

UNVERIFIED PROFILE

Are you Albert Torri?   Register this Author

Register author
Albert Torri

Albert Torri

Publications by authors named "Albert Torri"

Are you Albert Torri?   Register this Author

19Publications

771Reads

36Profile Views

Mitigating target interference in bridging immunogenicity assay with target-blocking reagents and mild basic pH.

Bioanalysis 2019 Jun 18. Epub 2019 Jun 18.

Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2018-0187DOI Listing
June 2019

Anti-VEGF drug interference with VEGF quantitation in the R&D systems human quantikine VEGF ELISA kit.

Bioanalysis 2019 Mar 20;11(5):381-392. Epub 2019 Mar 20.

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2018-0096DOI Listing
March 2019

2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 - LBA/cell-based assays: immunogenicity, biomarkers and PK assays).

Bioanalysis 2018 Nov 29. Epub 2018 Nov 29.

Amador Bioscience, Pleasanton, CA, USA (formerly of OncoMed, Redwood City, CA, USA).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2018-0287DOI Listing
November 2018

Bridging immunogenicity assays for IgG4 therapeutics: mitigating interference from Fc-Fc interactions.

Bioanalysis 2017 May 10;9(9):707-717. Epub 2017 May 10.

Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio-2017-0011DOI Listing
May 2017

Antidrug Antibodies in Patients Treated with Alirocumab.

N Engl J Med 2017 04 17;376(16):1589-90. Epub 2017 Mar 17.

University of Edinburgh, Edinburgh, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1616623DOI Listing
April 2017

Matrix interference from Fc-Fc interactions in immunoassays for detecting human IgG4 therapeutics.

Bioanalysis 2015 27;7(20):2701-12. Epub 2015 Oct 27.

Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio.15.152DOI Listing
August 2016

Effects of blood processing and sample storage on the stability of biotherapeutics and anti-drug antibodies.

Bioanalysis 2015 ;7(11):1325-35

Department of Bioanalytical Sciences, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA.

View Article

Download full-text PDF

Source
http://www.future-science.com/doi/10.4155/bio.15.66
Publisher Site
http://dx.doi.org/10.4155/bio.15.66DOI Listing
March 2016

Minimizing target interference in PK immunoassays: new approaches for low-pH-sample treatment.

Bioanalysis 2013 Aug;5(15):1897-910

Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA. michael.partridge@ regeneron.com

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio.13.128DOI Listing
August 2013

Benzyl amide-ketoacid inhibitors of HIV-integrase.

Bioorg Med Chem Lett 2007 Sep 14;17(17):4886-90. Epub 2007 Jun 14.

Department of Medicinal Chemistry, Research and Development, Bristol-Myers Squibb, The Richard L Gelb Center for Pharmaceutical Research and Development, Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.06.042DOI Listing
September 2007

Exploration of the diketoacid integrase inhibitor chemotype leading to the discovery of the anilide-ketoacids chemotype.

Bioorg Med Chem Lett 2006 Nov 12;16(22):5818-21. Epub 2006 Sep 12.

Department of Medicinal Chemistry, Pharmaceutical Research Institute, Bristol-Myers Squibb, The Richard L Gelb Center for Pharmaceutical Research and Development, 5 Research Parkway Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.08.075DOI Listing
November 2006

Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.

Bioorg Med Chem Lett 2006 Jun 20;16(11):2920-4. Epub 2006 Mar 20.

Department of Medicinal Chemistry, Pharmaceutical Research Institute, Bristol-Myers Squibb, The Richard L Gelb Center for Pharmaceutical Research and Development, 5 Research Parkway Wallingford, CT 06492, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0960894X0600288
Publisher Site
http://dx.doi.org/10.1016/j.bmcl.2006.03.010DOI Listing
June 2006